NIH-funded research NIH-funded research

Developing vaccines and therapeutics through program analysis and planning.

Official title: DCP - COPTRG - SELECT/PCPT

Funded at Leidos Biomedical Research, INC. · NIH-11219777 · Data updated 2026-11-12

This study is working on making better vaccines and treatments by looking closely at how they are developed, so that patients can have more effective options in the future.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionLeidos Biomedical Research, INC.
NIH-funded
Lab location1 site (Frederick, United States)
Project startSeptember 28, 2024
Project endAugust 30, 2025
Funding year2024
Award (this year)$1,514,138
NIH project number75N91019D00024-0-759102400011-18
Project IDNIH-11219777 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation or benefit are individuals who may require new vaccine or therapeutic options for their health conditions.

Less likely to help

Patients who are not seeking new vaccine or therapeutic options may not receive benefit from this research.

What this research studies

This research focuses on creating effective development plans for vaccines and therapeutics by conducting thorough program analysis. The team will assess various aspects such as preclinical strategies, manufacturing capacities, and regulatory requirements to ensure successful clinical development. By identifying and addressing deficiencies in these areas, the project aims to streamline the transition to advanced clinical testing. Patients may benefit from improved vaccine and therapeutic options that are developed through this comprehensive approach.

Why it matters

Potential benefit: If successful, this research could lead to the development of more effective vaccines and therapeutics for various conditions.

How similar studies have gone: Other research has shown success in developing vaccines and therapeutics through similar comprehensive program analysis approaches.

Where this research is happening

  • Leidos Biomedical Research, INC.
    Frederick, United States
    Active

Researchers

  • Principal investigator: Briscoe, Lynn — Leidos Biomedical Research, INC.
  • Study coordinator: Briscoe, Lynn

Related research

Other NIH-funded projects on the same topics.

  • Improving public health responses to COVID-19 through standardized testing.

    This study is looking to improve how we fight COVID-19 by testing blood samples to see if people have had the virus, and it’s designed for anyone interested in better ways to manage the disease.

    NIH research Leidos Biomedical Research, INC. · Frederick, United States · NIH-11220317

  • Creating a large library of cancer models for research use

    This study is creating a collection of new cancer models to help researchers and companies find better ways to treat cancer, making it easier for everyone to work together and share ideas.

    NIH research Leidos Biomedical Research, INC. · Frederick, United States · NIH-11219823

  • Advancing global cancer control through data analysis and international collaboration

    This study is all about helping countries around the world work better together to fight cancer by sharing important information and training scientists, especially in places that need extra support.

    NIH research Leidos Biomedical Research, INC. · Frederick, United States · NIH-11219804

  • Support for HIV and HPV cancer prevention clinical trials in the Americas

    This study is working on new vaccines and treatments to help prevent cancers related to HIV and HPV, making sure that patients in the US, Latin America, and the Caribbean can access better options as these exciting trials move forward.

    NIH research Leidos Biomedical Research, INC. · Frederick, United States · NIH-11219802

  • Development and production of clinical-grade biopharmaceuticals

    This study is all about making safe and effective new medicines, like vaccines and treatments for various conditions, so that patients can have access to the latest therapies that meet high-quality standards.

    NIH research Leidos Biomedical Research, INC. · Frederick, United States · NIH-11219801

  • Understanding the immune response to COVID-19

    This study is looking for ways to improve COVID-19 testing and understand how our immune system fights the virus, and you can help by sharing samples to make these tests better for everyone.

    NIH research Leidos Biomedical Research, INC. · Frederick, United States · NIH-11219800

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.